110 related articles for article (PubMed ID: 26475419)
1. Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy.
Wan X; Peng L; Ma J; Chen G; Li Y
Clin Ther; 2015 Nov; 37(11):2515-2526.e5. PubMed ID: 26475419
[TBL] [Abstract][Full Text] [Related]
2. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
Lee JH; Glick HA; Hayman JA; Solin LJ
J Clin Oncol; 2002 Jun; 20(11):2713-25. PubMed ID: 12039934
[TBL] [Abstract][Full Text] [Related]
3. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
[TBL] [Abstract][Full Text] [Related]
4. Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.
Frasier LL; Holden S; Holden T; Schumacher JR; Leverson G; Anderson B; Greenberg CC; Neuman HB
JAMA Oncol; 2016 Jan; 2(1):95-101. PubMed ID: 26539936
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting.
Bai Y; Ye M; Cao H; Ma X; Xu Y; Wu B
Breast Cancer Res Treat; 2012 Nov; 136(2):547-57. PubMed ID: 23053654
[TBL] [Abstract][Full Text] [Related]
7. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
[TBL] [Abstract][Full Text] [Related]
8. Is the use of radiation therapy after mastectomy cost-effective?
Hayman JA; Hillner BE
Semin Radiat Oncol; 1999 Jul; 9(3):287-91. PubMed ID: 10378968
[TBL] [Abstract][Full Text] [Related]
9. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
10. Postmastectomy radiotherapy: a review.
Kunkler IH; Chua BH
Curr Opin Oncol; 2021 Nov; 33(6):547-552. PubMed ID: 34494609
[TBL] [Abstract][Full Text] [Related]
11. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
12. National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer.
Minami CA; Bilimoria KY; Hansen NM; Strauss JB; Hayes JP; Feinglass JM; Bethke KP; Rydzewski NR; Winchester DP; Palis BE; Yang AD
Ann Surg Oncol; 2016 Aug; 23(8):2446-55. PubMed ID: 27169774
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.
Liberato NL; Marchetti M; Barosi G
J Clin Oncol; 2007 Feb; 25(6):625-33. PubMed ID: 17308267
[TBL] [Abstract][Full Text] [Related]
14. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
Sher DJ; Wittenberg E; Suh WW; Taghian AG; Punglia RS
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):440-6. PubMed ID: 18963542
[TBL] [Abstract][Full Text] [Related]
15. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.
Hayman JA; Hillner BE; Harris JR; Weeks JC
J Clin Oncol; 1998 Mar; 16(3):1022-9. PubMed ID: 9508186
[TBL] [Abstract][Full Text] [Related]
17. Post-mastectomy radiation therapy in breast cancer with 1-3 involved lymph nodes: the Pros.
Tada K; Nishioka K; Kikuchi Y; Niwa T; Seto Y
Breast Cancer; 2017 Jul; 24(4):502-504. PubMed ID: 28585002
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer.
Yang J; Qi SN; Fang H; Song YW; Jin J; Liu YP; Wang WH; Yang Y; Tang Y; Ren H; Chen B; Lu NN; Tang Y; Li N; Jing H; Wang SL; Li YX
Breast; 2021 Aug; 58():72-79. PubMed ID: 33933925
[TBL] [Abstract][Full Text] [Related]
19. The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.
Cassidy RJ; Liu Y; Kahn ST; Jegadeesh NK; Liu X; Subhedar PD; Arciero CA; Gillespie TW; Torres MA
Cancer; 2017 Aug; 123(15):2829-2839. PubMed ID: 28387923
[TBL] [Abstract][Full Text] [Related]
20. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
Smith BD; Smith GL; Haffty BG
J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]